Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Morishita Jintan CoTSE:4524 66 Days Payable is 55.90 as of Mar. 2026, which is 19% below its 10-year median of 69.14. GuruFocus rates TSE:4524 with a GF Score™ of 66/100 and a GF Value™ of 円2,222.64 (Fairly Valued). The stock has 5 warning signs investors should review. Among 927 Drug Manufacturers companies, Morishita Jintan Co ranks worse than 68.39% on this metric.
The historical rank and industry rank for Morishita Jintan Co's Days Payable or its related term are showing as below:
TSE:4524'
s Days Payable Range Over the Past 10 Years
Min: 58.23 Med: 69.14 Max: 77.2
Current: 59.25
During the past 13 years, Morishita Jintan Co's highest Days Payable was 77.20. The lowest was 58.23. And the median was 69.14.
TSE:4524's Days Payable is ranked worse than 68.39% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs TSE:4524: 59.25
Morishita Jintan Co's Days Payable
declined
from Mar. 2025 (65.23) to Mar. 2026 (55.90).
It may suggest that Morishita Jintan Coaccelerated paying its suppliers.
Morishita Jintan Co Days Payable Related Terms
Morishita Jintan Co Days Payable Historical Data
* Premium members only.
The historical data trend for Morishita Jintan Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Morishita Jintan Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Morishita Jintan Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Morishita Jintan Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Morishita Jintan Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Morishita Jintan Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Morishita Jintan Co (TSE:4524) has a Days Payable of 55.90 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Morishita Jintan Co and its competitors. This is 19% below median its historical median of 69.14. Over the past decade, Morishita Jintan Co's Days Payable has ranged from 58.23 to 77.20. According to the industry distribution chart, Morishita Jintan Co ranks #634 out of 927 companies in the Drug Manufacturers industry, placing it in the top 68.4%.
Is Morishita Jintan Co's Days Payable too high?
Morishita Jintan Co's current Days Payable of 55.90 is 19% below median its 10-year median of 69.14. Over the past 10 years, this metric has ranged from a low of 58.23 to a high of 77.20. The Drug Manufacturers industry median Days Payable is 90.38. Morishita Jintan Co's value of 55.90 is 38.2% below this industry median. Based on the distribution chart, Morishita Jintan Co ranks #634 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Morishita Jintan Co has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Morishita Jintan Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Morishita Jintan Co ranks #634 out of 927 companies for Days Payable. This places Morishita Jintan Co in the lower half of its industry. The industry median Days Payable is 90.38. Morishita Jintan Co's value of 55.90 is 38.2% below this benchmark. Historically, Morishita Jintan Co's own Days Payable has ranged from 58.23 to 77.20 over the past decade. While the company's 10-year median is 69.14 vs. the industry median of 90.38, Morishita Jintan Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Morishita Jintan Co's current Days Payable of 55.90 is 38.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Morishita Jintan Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Morishita Jintan Co's current Days Payable is 55.90, which is 19% below median its own 10-year median of 69.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morishita Jintan Co stock overvalued right now?
Based on GuruFocus' analysis, Morishita Jintan Co (TSE:4524) is currently considered Fairly Valued. The stock's GF Value™ is 円2,222.64, compared to a current price of 円2,171.00 — trading 2.3% below its estimated fair value. The current Days Payable is 55.90, which is 19% below median its 10-year median of 69.14 and 38.2% below the Drug Manufacturers industry median of 90.38. Morishita Jintan Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Morishita Jintan Co (TSE:4524), the current Days Payable is 55.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Morishita Jintan Co (TSE:4524) Overvalued in 2026?
Based on GuruFocus' analysis, Morishita Jintan Co stock appears to be undervalued.
The current stock price of 円2,171.00 is trading 2.3% below its estimated GF Value™ of 円2,222.64.
GuruFocus considers Morishita Jintan Co to be Fairly Valued.
Key valuation signals for TSE:4524:
Days Payable: 55.90 (19% below median its 10-year median of 69.14)
GF Value™: 円2,222.64 vs. price of 円2,171.00 (2.3% below fair value)
Industry Position: 38.2% below the Drug Manufacturers median (#634 of 927)
No single metric tells the full story. See the TSE:4524 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Morishita Jintan Co Ltd is engaged in the manufacturing and sale of pharmaceuticals, quasi-drugs, health foods, medical devices, and food. The company's product offerings include dietary supplements, food drinks, cosmetics, products for medical institutions, functional foods, and others.
66GF Score
Get the complete analysis for TSE:4524
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4524 has been successfully added to your 
